Sort by
Refine Your Search
-
by chemical exposures. Develop educational tools describing relative risks of chemical exposures. Contribute to public policies related to environmental and occupational chemical risks. Offer training
-
processes, etc., to develop the skills necessary to perform the required functions. Understands and adheres to Rutgers’ compliance standards as they appear in RBHS’s Corporate Compliance Policy, Code
-
information on benefits and eligibility, please visit: http://uhr.rutgers.edu/benefits/benefits-overview . Posting Summary The Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey is
-
voluntary tax-deferred savings options Employee and dependent educational benefits Life insurance coverage Employee discounts programs For detailed information on benefits and eligibility, please visit: http
-
of areas including strongly correlated fermion materials, high-temperature superconductivity, topological electronic states of matter, developments and applications of computational methods
-
% research time freely to develop independent interests aligned with lab’s research topics including Arginylation, Cell Engineering, Chemical Proteomics, Degrader Development, Drug Discovery, Proteomics, PTMs
-
savings options Employee and dependent educational benefits Life insurance coverage Employee discounts programs For detailed information on benefits and eligibility, please visit: http://uhr.rutgers.edu
-
inference methods in these data, assemble and summarize relevant literature, and will be encouraged to develop their own independent research program in maternal and child health and/or housing and
-
learning. Candidates with experience in method development and high-performance computing are especially encouraged to apply. A Ph.D. in chemistry, physics, computer science, or a related field is required
-
the Department of Medicinal Chemistry on or about November 3, 2025. The successful candidates will participate in NIH-funded research projects in designing and developing small molecule antivirals targeting